• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

饮食调节人类结肠微生物群:更新益生元概念。

Dietary modulation of the human colonic microbiota: updating the concept of prebiotics.

机构信息

Food Microbial Sciences Unit, School of Food Biosciences, The University of Reading, Reading, UK.

出版信息

Nutr Res Rev. 2004 Dec;17(2):259-75. doi: 10.1079/NRR200479.

DOI:10.1079/NRR200479
PMID:19079930
Abstract

Prebiotics are non-digestible (by the host) food ingredients that have a beneficial effect through their selective metabolism in the intestinal tract. Key to this is the specificity of microbial changes. The present paper reviews the concept in terms of three criteria: (a) resistance to gastric acidity, hydrolysis by mammalian enzymes and gastrointestinal absorption; (b) fermentation by intestinal microflora; (c) selective stimulation of the growth and/or activity of intestinal bacteria associated with health and wellbeing. The conclusion is that prebiotics that currently fulfil these three criteria are fructo-oligosaccharides, galacto-oligosaccharides and lactulose, although promise does exist with several other dietary carbohydrates. Given the range of food vehicles that may be fortified by prebiotics, their ability to confer positive microflora changes and the health aspects that may accrue, it is important that robust technologies to assay functionality are used. This would include a molecular-based approach to determine flora changes. The future use of prebiotics may allow species-level changes in the microbiota, an extrapolation into genera other than the bifidobacteria and lactobacilli, and allow preferential use in disease-prone areas of the body.

摘要

益生元是指那些无法被(宿主)消化的食物成分,它们通过在肠道中的选择性代谢而产生有益的影响。关键在于微生物变化的特异性。本文从三个标准来综述这个概念:(a)抵抗胃酸、哺乳动物酶的水解和胃肠道吸收;(b)在肠道微生物群中发酵;(c)选择性刺激与健康和福祉相关的肠道细菌的生长和/或活性。结论是,目前符合这三个标准的益生元是果寡糖、半乳寡糖和乳果糖,尽管其他几种膳食碳水化合物也有希望。鉴于可能通过益生元强化的各种食物载体,它们能够带来积极的微生物群变化以及可能产生的健康方面的影响,因此使用稳健的功能测定技术非常重要。这将包括一种基于分子的方法来确定菌群变化。未来益生元的使用可能会使微生物群发生种水平的变化,不仅限于双歧杆菌和乳杆菌属,还可以优先用于身体易患病的部位。

相似文献

1
Dietary modulation of the human colonic microbiota: updating the concept of prebiotics.饮食调节人类结肠微生物群:更新益生元概念。
Nutr Res Rev. 2004 Dec;17(2):259-75. doi: 10.1079/NRR200479.
2
Prebiotic effects: metabolic and health benefits.益生元作用:代谢与健康益处。
Br J Nutr. 2010 Aug;104 Suppl 2:S1-63. doi: 10.1017/S0007114510003363.
3
Relationship of prebiotics and food to intestinal microflora.益生元及食物与肠道微生物群的关系。
Eur J Nutr. 2002 Nov;41 Suppl 1:I11-6. doi: 10.1007/s00394-002-1102-7.
4
Dietary modulation of the human gut microflora using prebiotics.使用益生元对人类肠道微生物群进行饮食调节。
Br J Nutr. 1998 Oct;80(4):S209-12.
5
Prebiotic effects of inulin and oligofructose.菊粉和低聚果糖的益生元效应。
Br J Nutr. 2002 May;87 Suppl 2:S193-7. doi: 10.1079/BJNBJN/2002537.
6
Probiotics, prebiotics, and synbiotics.益生菌、益生元及合生元。
Adv Biochem Eng Biotechnol. 2008;111:1-66. doi: 10.1007/10_2008_097.
7
Food-based strategies to modulate the composition of the intestinal microbiota and their associated health effects.基于食物的策略来调节肠道微生物群的组成及其相关的健康影响。
J Physiol Pharmacol. 2009 Dec;60 Suppl 6:5-11.
8
[Prebiotics: concept, properties and beneficial effects].[益生元:概念、特性及有益作用]
Nutr Hosp. 2015 Feb 7;31 Suppl 1:99-118. doi: 10.3305/nh.2015.31.sup1.8715.
9
[Probiotics].[益生菌]
Zentralbl Gynakol. 2003 Dec;125(12):475-9. doi: 10.1055/s-2003-44811.
10
Review article: prebiotics in the gastrointestinal tract.综述文章:胃肠道中的益生元
Aliment Pharmacol Ther. 2006 Sep 1;24(5):701-14. doi: 10.1111/j.1365-2036.2006.03042.x.

引用本文的文献

1
Activation of chicken macrophages by isomalto/malto-polysaccharide (IMMP) is facilitated by toll-like receptor 4 (TLR4).异麦芽糖/麦芽多糖(IMMP)对鸡巨噬细胞的激活由Toll样受体4(TLR4)介导。
Poult Sci. 2025 Aug 14;104(11):105690. doi: 10.1016/j.psj.2025.105690.
2
Laxative effect of Zengye granule by modulating the SCF/c-Kit pathway and gut microbiota in constipated mice.增液颗粒通过调节便秘小鼠的SCF/c-Kit通路和肠道微生物群发挥通便作用。
Front Vet Sci. 2025 Jun 18;12:1628570. doi: 10.3389/fvets.2025.1628570. eCollection 2025.
3
Co-Encapsulation of Probiotics and Prebiotics: Techniques and Applications in Food Fortification.
益生菌与益生元的共包封:食品强化中的技术与应用
Food Sci Nutr. 2025 Jun 18;13(6):e70426. doi: 10.1002/fsn3.70426. eCollection 2025 Jun.
4
The gut-heart axis: unveiling the roles of gut microbiota in cardiovascular diseases.肠-心轴:揭示肠道微生物群在心血管疾病中的作用
Front Cardiovasc Med. 2025 May 26;12:1572948. doi: 10.3389/fcvm.2025.1572948. eCollection 2025.
5
Probing and manipulating the gut microbiome with chemistry and chemical tools.运用化学及化学工具探究和操控肠道微生物群。
Gut Microbiome (Camb). 2025 Apr 14;6:e6. doi: 10.1017/gmb.2025.4. eCollection 2025.
6
Effects of Supplementation with Encapsulated Different Postbiotics, Alone or with Inulin, on Growth Performance, Carcass and Organ Characteristics, Blood Parameters, Growth Hormone, and Insulin-like Growth Factor mRNA in Broilers.单独或与菊粉一起添加包封的不同后生元对肉鸡生长性能、胴体和器官特征、血液参数、生长激素以及胰岛素样生长因子mRNA的影响。
Animals (Basel). 2025 Mar 31;15(7):1010. doi: 10.3390/ani15071010.
7
Advances in gut microbiota-related treatment strategies for managing colorectal cancer in humans.人类结直肠癌肠道微生物群相关治疗策略的进展
Cancer Biol Med. 2025 Mar 12;22(2):93-112. doi: 10.20892/j.issn.2095-3941.2024.0263.
8
Microencapsulation of Probiotics for Enhanced Stability and Health Benefits in Dairy Functional Foods: A Focus on Pasta Filata Cheese.用于提高乳制品功能食品中益生菌稳定性及健康益处的微胶囊化:以丝状干酪为例
Pharmaceutics. 2025 Feb 2;17(2):185. doi: 10.3390/pharmaceutics17020185.
9
Gut Microbiota Profile and Functional Gastrointestinal Disorders in Infants: A Longitudinal Study.婴儿肠道微生物群特征与功能性胃肠疾病:一项纵向研究
Nutrients. 2025 Feb 16;17(4):701. doi: 10.3390/nu17040701.
10
Green Tea with Rhubarb Root Reduces Plasma Lipids While Preserving Gut Microbial Stability in a Healthy Human Cohort.大黄根绿茶可降低健康人群的血脂,同时维持肠道微生物稳定性。
Metabolites. 2025 Feb 19;15(2):139. doi: 10.3390/metabo15020139.